Quethera Limited

Active08450540 Private limited company
Incorporated
19 March 2013 (13 years)
Industry
Research and experimental development on biotechnology (72110)
Owned by
Astellas Pharma Inc.
Accounts type
Full
Region
South East
Address
300 Dashwood Lang Road
Bourne Business Park
Addlestone
KT15 2NX

Filing status

Accounts due
31 December 2027
Last accounts
31 March 2026
Conf. stmt due
2 April 2027
Last conf. stmt
19 March 2026

Officers 3 active

Officer details are public data from the Companies House register.

Director · Appointed 1 February 2026
British
Born October 1967 (59)
Higashitani, Chieri, Ms.
Director · Appointed 18 June 2025
American
Born January 1980 (46)
Director · Appointed 18 June 2025
British
Born December 1965 (60)
Officer history (15 former)
1 February 2026
Appointed Flowerdew, Lesley Ann as Director
10 December 2025
Resigned Hall, Stephen Andrew as Director
19 June 2025
Resigned Seddon, Natalie Louise as Director
18 June 2025
Appointed Higashitani, Chieri, Ms. as Director
18 June 2025
Appointed Mortlock, Andrew Austen, Dr. as Director
1 April 2025
Appointed Hall, Stephen Andrew as Director
31 March 2025
Resigned Mcdougall, Alan, Dr as Director
31 March 2025
Resigned Sawamoto, Taiji as Director
1 April 2022
Appointed Sawamoto, Taiji as Director
1 April 2022
Appointed Mcdougall, Alan, Dr as Director
31 March 2022
Resigned Pearson, Adam John as Director
31 March 2022
Resigned Tomura, Yuichi, Mr. as Director
1 April 2020
Appointed Pearson, Adam John as Director
1 April 2020
Appointed Seddon, Natalie Louise as Director
31 March 2020
Resigned Jonsson, Timothy Philip, Mr. as Director
31 March 2020
Resigned Hirano, Masaaki, Mr. as Director
10 August 2018
Resigned Morgan, Piers John as Director
10 August 2018
Appointed Tomura, Yuichi, Mr. as Director
10 August 2018
Appointed Hirano, Masaaki, Mr. as Director
10 August 2018
Resigned Dobree, Anne Michelle, Dr as Director
10 August 2018
Appointed Jonsson, Timothy Philip, Mr. as Director
10 August 2018
Resigned Sexton, Peter Oliver Wharton as Director
10 August 2018
Resigned Widdowson, Peter Stuart as Director
10 August 2018
Resigned Martin, Keith Robert, Professor as Director
28 February 2018
Appointed Dobree, Anne Michelle, Dr as Director
28 February 2018
12 June 2017
Appointed Holbrook, David Mark Anthony, Dr as Director
12 June 2017
Resigned Hardiman, Bradley William as Director
17 August 2016
Appointed Morgan, Piers John as Director
1 September 2015
Appointed Sexton, Peter Oliver Wharton as Director
1 September 2015
Appointed Hardiman, Bradley William as Director
30 June 2015
Appointed Martin, Keith Robert, Professor as Director
19 March 2013
Appointed Widdowson, Peter Stuart as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Astellas Pharma Inc.
Corporate entity · Notified 10 August 2018
Owns 75–100% of shares
Public Company
Reg. no. 0199-01-034966
Former controllers (1)
10 August 2018
Ceased Peter Stuart Widdowson — Owns 25–50% of shares

Filings 85

DateDescriptionMade Up ToPagesPDF
17 July 2026Full accounts31 March 2026
30 March 2026Confirmation statement with updates19 March 2026
10 February 2026Statement of capital following an allotment of shares
5 February 2026Appointment of a director
28 January 2026Termination of appointment of a director
Show all 85 filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?